Sandbox/Rate Control Strategy: Difference between revisions
Created page with "__NOTOC__ {{CMG}} ===Rate Control Strategy=== <span style="font-size:85%">'''Abbreviations:''' '''AF''': Atrial fibrillation; '''COPD''': Chronic obstructive pulmonary disea..." |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{CMG}} | {{CMG}}; {{M.P}} | ||
===Rate Control Strategy=== | ===Rate Control Strategy=== |
Revision as of 01:02, 5 May 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Mugilan Poongkunran M.B.B.S [2]
Rate Control Strategy
Abbreviations: AF: Atrial fibrillation; COPD: Chronic obstructive pulmonary disease; CVD: Cardiovascular disease; EF: Ejection fraction; HFpEF: Heart failure with preserved ejection fraction; HFrEF: Heart failure with reduced ejection fraction; LV: Left ventricle; HF: Heart failure; HR: Heart rate
Stable AF patients requiring heart rate control therapy | |||||||||||||||||||||||||||||||||||||||||||||||||||
Does the patient have any evidence of an accessory pathway (pre-excitation syndrome)? | |||||||||||||||||||||||||||||||||||||||||||||||||||
Yes | No | ||||||||||||||||||||||||||||||||||||||||||||||||||
COPD | HFrEF or LV dysfunction | Hypertension or HFpEF or No CVD | |||||||||||||||||||||||||||||||||||||||||||||||||
❑ Nondihydropyridine calcium channel blockers: Most preferred | ❑ Beta blockers: After stabilization in patients with decompensated HF | ❑ Beta blockers | ❑ Procainamide | ||||||||||||||||||||||||||||||||||||||||||||||||
❑ Amiodarone | Consider catheter ablation if the accessory pathway has a short refractory period that allows rapid antegrade conduction | ||||||||||||||||||||||||||||||||||||||||||||||||||